This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Elite Serum Undergoes Extensive Testing By Bureau Veritas

MIAMI, April 8, 2013 /PRNewswire/ -- Created in 1828, Bureau Veritas is the global leader in Testing, Inspection and Certification (TIC), delivering high quality services to help clients meet the growing challenges of quality, safety, environmental protection and social responsibility.  Elite Serum, made by cosmeceutical laboratory SkinPro, is an award-winning anti-aging eye serum that is widely considered to be the first viable topical alternative to Botulinum Toxin injections. For the past 45 days, Elite Serum has undergone extensive independent testing among a 30 member consumer panel assembled by Bureau Veritas. The results of this testing proves that Elite Serum reduces fine lines and wrinkles, dark under eye circles and under eye puffiness. All of these symptoms were positively affected in varying degrees of efficacy across the panel spectrum.

(Logo: http://photos.prnewswire.com/prnh/20130307/FL72444LOGO )

Panelists had the following comments to make regarding their experience with Elite Serum:

"I like the feel of the product and I like the syringe dispenser very much."

"This serum did not make the skin around my eyes feel dry like some serums do. I was happy with the product."

"The darkness under my eyes did seem to lessen."

"My right eyelid was closing slightly before using the product. It is now opened fully due to the serum!"

"I only had slight wrinkles and fine lines but I could see a difference after the first couple weeks."

"I have very sensitive skin, but I have found the serum to be very comfortable to use and easy to apply."

"I liked the feel of the product - it never stung my eyes. I also liked that there was no scent to it."

Further to these positive independent panel results that confirm the efficacy of Elite Serum among ordinary consumers, the medical community has also embraced this product with a profound appreciation of its underlying effectiveness. Dr. Mark Weis MD, an anti-aging specialist from the University of Kansas College School of Medicine, remarked, "My patients' experience has confirmed Elite Serum's impressive effectiveness in reducing age-related skin concerns around the eyes." Heralded by both doctors and consumers alike, Elite Serum is available for sale nationwide at select medical centers or online at www.EliteSerum.com. For more information about this product, please contact SkinPro at 1-800-575-2065.

SOURCE SkinPro

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs